Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.2393
+0.0037 (1.57%)
At close: Oct 23, 2026, 4:00 PM EDT
0.2400
+0.0007 (0.29%)
Pre-market: Oct 26, 2026, 8:08 AM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $21.99 million as of October 23, 2026. It is the 36,229th most valuable company in the world and the 5,149th biggest in the United States. Its market cap has decreased by 79.74% in one year.
Market Cap
21.99M
Enterprise Value
-20.76M
1-Year Change
-79.74%
Global Rank
Country Rank
#5,149 United States
Category
ChartMarket Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has decreased from $51.03M to $21.99M, a decrease of -56.91%. That is a compound annual growth rate of -15.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 21.99M | -83.72% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 25.95M |
| IGC Pharma | 25.43M |
| Immutep | 23.84M |
| NextCure | 22.80M |
| Polyrizon | 21.19M |
| Seres Therapeutics | 20.99M |
| Quoin Pharmaceuticals | 19.31M |
| Akari Therapeutics, | 18.80M |